Market Trends of Europe Mass Spectrometry Industry
This section covers the major market trends shaping the Europe Mass Spectrometry Market according to our research experts:
Triple Quadrupole (Tandem Mass Spectrometry Devices) Segment is Expected to Dominate the Market over the Forecast Period
Triple Quadrupole mass spectrometry devices are currently in high demand due to their wide applications and ease of use. Conventional hospital diagnostic assays are based on clinical chemistry and immunoassay techniques that require analyte-specific reagents and antibodies. The combination of liquid chromatography and tandem mass spectrometry allows unequivocal identification of traces of antibiotics and antibacterial agents in complex biological matrices. The increasing research in genetics, especially proteomics and the application of Tandem MS for the same, is propelling the growth of the market. The tandem mass spectrometry market has immense opportunities in various industries for several applications, like environmental water sampling (detection of contaminants, pesticides), clinical diagnostics, etc.
With the technological advancement in mass spectrometry and other analytics techniques, the key companies in the market are coming up with new product launches, which is one of the factors responsible for the growth of the segment. For instance, in June 2022, Agilent Technologies Inc. revealed its Agilent 6475 triple quadrupole LC/MS system along with another instrument at the 70th ASMS Conference on Mass Spectrometry and Allied Topics, and as per the company, the Agilent 6475 triple quadrupole LC/MS system is the next evolution in a sensitive, rugged, robust mass spectrometer. The 6475 incorporates intelligent reflex, an automated sample reinjection function that intelligently 'reflexes' to specific analysis conditions providing immediate validation of results, further improving the speed of analysis and reducing operator involvement
Hence, from the abovementioned factors, the Triple Quadrupole mass spectrometer is expected to witness healthy growth over the forecast period. High investment in the research and development activities by pharmaceutical and biotechnology companies and new technological advancements in mass spectrometer devices will also boost the growth of the studied market during the forecast period.
Germany is Expected to Hold a Significant Share in the Market Over the Forecast Period
Germany holds a major share in the mass spectrometry market and is expected to show a similar trend over the forecast period mainly due to the increased funding for mass spectrometry, research and development activities related to mass spectrometry, widespread usage of mass spectrometer instruments in the life sciences, and the presence of key market players in the region. According to the data from OECD published in November 2022, the R&D spending in Germany was around USD 7,382.9 per capita. The high R&D expenditure indicates increased spending on crucial technologies such as mass spectrometry.
Additionally, the strategic activities of the key market players are expected to drive the growth of the studied market in Germany. For instance, in August 2021, the Organic Mass Spectroscopy team at Thermo Fisher Scientific Bremen, Germany, took initiative for a sustainable future in mass spectroscopy and announced the ambitious IsoFootprint Project. The IsoFootprint Project is an initiative to remove all CO2 emissions associated with the manufacturing and production of all new instruments. Such initiatives are expected to contribute to the growth of the market over the forecast period in Germany.
In September 2021, the first Net Zero Mass Spectrometer was launched to Support Greener Future in Germany. The Thermo Scientific Delta Q Isotope Ratio Mass Spectrometer (IRMS) is a next-generation gas IRMS designed to enable detailed analysis with greater precision and accuracy. Thus, owing to the above factors, the market is expected to grow in Germany during the forecast period.
